CA
NZ
UK
AU
IND
US
● Immix released interim NEXICART-2 data on NXC-201 in relapsed or refractory AL amyloidosis on September 29, 2026.
● Summit Therapeutics shares soared on September 29, 2026, closing at $17.96 after AstraZeneca agreed to a $2 billionEquityinvestment.
● Summit Therapeutics closed at $17.96 on Tuesday, September 29, 2026, after AstraZeneca agreed to a $2 billion strategicEquityinvestment.
● AbbVie shares slipped to about $263.54 on Tuesday, September 29, 2026, as investors digested an FDA approval.
● The FDA set a December 22, 2026 target action date for lorundrostat in adults with hypertension.
● The FDA issued warning letters to Neogen and contract manufacturer Sciarra Aeromed over fungal contamination in Neogen Vet HYCOAT.
● GeneDx shares closed at $75.79 on Tuesday, September 29, down 11.80% from the prior close of $85.93.
● Structure Therapeutics closed at $32.69 on Tuesday, September 29, down 6.77% from the prior close of $35.07.
● PacBio (PACB) closed at $1.71 on Monday, up about 5.6% from $1.62, trading between $1.59 and $1.80 during the session.
● Mirum Pharmaceuticals (MIRM) closed at $87.96 on Monday, down about 1.9% from $89.70, after trading between $84.71 and $91.25.
Please wait processing your request...